GSTC (GlobeStar Therapeutics) Accounts Payable: $0.44 Mil (As of Jun. 2024)


What is GlobeStar Therapeutics Accounts Payable?

GlobeStar Therapeutics GSTC -99.00% Accounts Payable is $0.44 Mil as of Jun. 2024.

GlobeStar Therapeutics's Accounts Payable for the quarter that ended in Jun. 2024 was $0.44 Mil.

GlobeStar Therapeutics's quarterly Accounts Payable increased from Dec. 2023 ($0.37 Mil) to Mar. 2024 ($0.41 Mil) and increased from Mar. 2024 ($0.41 Mil) to Jun. 2024 ($0.44 Mil).

GlobeStar Therapeutics's annual Accounts Payable increased from Sep. 2021 ($0.22 Mil) to Sep. 2022 ($0.38 Mil) but then declined from Sep. 2022 ($0.38 Mil) to Sep. 2023 ($0.33 Mil).

GlobeStar Therapeutics Accounts Payable Related Terms

GlobeStar Therapeutics Accounts Payable Historical Data

* Premium members only.

The historical data trend for GlobeStar Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GlobeStar Therapeutics Accounts Payable Chart

GlobeStar Therapeutics Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 0.13 0.22 0.38 0.33

GlobeStar Therapeutics Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.49 0.33 0.37 0.41 0.44

GlobeStar Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.44 Mil mean?
GlobeStar Therapeutics (GSTC) has a Accounts Payable of $0.44 Mil as of Jun. 2024. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on GlobeStar Therapeutics and its competitors.
Is GlobeStar Therapeutics' Accounts Payable too high?
GlobeStar Therapeutics' current Accounts Payable is $0.44 Mil.
How does GlobeStar Therapeutics' Accounts Payable compare to GBLX and ENDV?
GlobeStar Therapeutics' Accounts Payable of $0.44 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on GlobeStar Therapeutics and its competitors. GlobeStar Therapeutics's current Accounts Payable is $0.44 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GlobeStar Therapeutics stock overvalued right now?
GlobeStar Therapeutics (GSTC) has a current Accounts Payable of $0.44 Mil. The current Accounts Payable is $0.44 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For GlobeStar Therapeutics (GSTC), the current Accounts Payable is $0.44 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GlobeStar Therapeutics Business Description

Address 719 Jadewin Avenue, Richland, WA, USA, 99352
GlobeStar Therapeutics Corp is a clinical-stage pharmaceutical company introducing a patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The company is focused on developing therapies for people with serious and life-threatening rare disorders.